Get startedLog in
    Picture of Apellis Pharmaceuticals logo

    APLS — Apellis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Apellis Pharmaceuticals Q4 Basic EPS USD 0.47

    Picture of Apellis Pharmaceuticals logoApellis Pharmaceuticals
    24/02/2026 12:05
    Feb 24 (Reuters) - Apellis Pharmaceuticals Q4 operating expenses USD 251.055 million.

Q4 product revenue USD 190.341 million

Q4 net income USD -58.951 million

Q4 operating income USD -51.142 million

    Recent news on Apellis Pharmaceuticals

    See all news